MESQUITE, NV / ACCESSWIRE / November 15, 2017 / Cannabis Sativa (OTCQB: CBDS) is proud to announce that Kyle Powers, Cofounder of PrestoDoctor, a Cannabis Sativa, Inc. subsidiary, made the Class of 2018 Forbes 30 Under 30 List of Young Stars, Visionaries and Creative Disruptors. Forbes described the group as "game changers in 20 industries all under 30 years old -- the most definitive gathering of today's leading young change-makers and innovators in the U.S." Forbes stated that "Kyle Powers built a custom telemedicine platform, PrestoDoctor, to make it easier for patients to get credentials to buy medical marijuana. Half the company was sold to publicly traded Cannabis Sativa at a $9 million valuation."
Cannabis Sativa, Inc. President David Tobias stated, "We are very proud of Kyle and the PrestoDoctor team for what they have accomplished. It is really exciting to see Forbes recognize the qualities we recognized in Kyle when deciding to move forward with the PrestoDoctor acquisition."
PrestoDoctor ("Presto") www.prestodoctor.com offers the greatest privacy and convenience while still offering fully qualified medical marijuana recommendations. Presto allows you to receive your medical marijuana recommendation from the comfort of your own home (currently, in California and Nevada only) - easy, fast, private. Presto is a member of the American Telemedicine Association and is HIPAA and HITECH compliant.Furthermore, Presto's doctors are licensed with the appropriate state medical boards and complete periodic marijuana training courses.
About Cannabis Sativa, Inc.:
Cannabis Sativa, Inc. ("CBDS") is engaged in the licensing of cannabis-related intellectual property, marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. CBDS licenses the "hi" and "White Rabbit" brands, holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, owns patent pending and trade secret formulas and processes, offers the hi benefits discount pharmacy card, and operates subsidiaries including: Wild Earth Naturals, Inc., (wildearthnaturals.com), iBudtender (www.ibudtender.com) and PrestoDoctor (www.prestodoctor.com). In addition, CBDS seeks strategic partners for the acquisition of operating companies, intellectual property and other assets which fit within the CBDS corporate vision.
This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company's success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
1646 West Pioneer Blvd Suite 120
Mesquite, NV 89027
SOURCE:Cannabis Sativa Inc.
© 2017 Accesswire. All Rights Reserved.